Solux Merger with Loss-Making Target Triggers Massive Dilution and Financial Risk
Solux will issue 54,359,959 new shares in the merger, a 103% dilution compared to existing shares. The largest shareholder's stake drops from 8.71% to 4.43% and further to 3.05% upon conversion rights, severely impairing existing shareholder value.
The surviving company recorded an operating loss of 7.06 billion KRW and net loss of 25.59 billion KRW in Q3 2025, while the target had an operating loss of 5.44 billion KRW and net loss of 8.32 billion KRW. Post-merger projected operating losses are 15.71 billion KRW for year-end 2025 and 3.5 billion KRW for Q1 2026, indicating poor profitability outlook.
The target's current ratio plummeted from 31.17% at end-Q3 2025 to 6.02% at end-Q1 2026, and its debt ratio surged to 281.33%. With accumulated deficit of 184.7 billion KRW and outstanding convertible bonds of 90.2 billion KRW, the financial structure is extremely fragile, posing high post-merger instability risk.
Solux was designated as an unfaithful disclosure company in 2024 and received 4.0 penalty points on December 31, 2025. The target had a 3-month suspension of cosmetics manufacturing in 2024 and failed three times in technology-special listing, indicating low governance credibility.
Post-merger treasury shares total 7,301,112 shares or 7.37% of total issued shares, but no cancellation plan exists, limiting shareholder return. Lock-up shares amount to 10,430,358 shares only 9.75% of total, leaving potential for massive overhang.
[AI Summary]Solux's merger with a financially distressed target forces a 103% dilution on existing shareholders, with continued operating losses expected post-merger. The target's liquidity crisis and high debt burden transfer to Solux, creating very high risk of stock value decline and investment loss.
KOSDAQ Filing Information
[Correction of Description] Securities Registration Statement (Merger)